Determinants and prognostic value of post-operative maximum urethral closure pressure after artificial urinary sphincter in men.

Artificial urinary sphincter Lower urinary tract dysfunction Stress urinary incontinence Urethral closure pressure Urodynamics

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
May 2020
Historique:
received: 25 05 2019
accepted: 19 07 2019
pubmed: 28 7 2019
medline: 29 1 2021
entrez: 27 7 2019
Statut: ppublish

Résumé

To evaluate the determinants and prognostic value of post-operative maximum urethral closure pressure (MUCP) after AUS implantation in male patients. The charts of all male patients who had an AUS implantation between 2008 and 2018 at a single center were reviewed retrospectively for an exploratory study. A post-operative urethral profilometry was performed systematically as part of routine daily practice over the study period to assess the post-operative MUCP with the AUS consecutively closed (c-MUCP) and opened (o-MUCP). The difference between c-MUCP and the manufacturer's theoretical pressure objective determined by the pressure regulating balloon (PRB) was calculated (diff-th-MUCP). The primary endpoint was social continence at 3 months defined as 0-1 protection/day. Ninety patients were included. The median age was 71 years, and the median follow-up was 50 months. The etiology of incontinence was radical prostatectomy in 84% of cases, and endoscopic prostate surgery in 6.6% of patients. There were 74.4% of patients who were socially continent at 3 months. The c-MCUP was significantly higher in the continent group (53 [42.2, 60.2] vs 62 [58, 70] p = 0.02). The diff-th-MUCP did not differ significantly between the two groups (18 [0, 23] vs 1 [- 2, 7.7] p = 0.29). The c-MUCP was not statistically associated with the risk of revision and/or explantation. The MUCP after AUS implantation in male patients often differs from the manufacturer's pressure objective. The postoperative c-MUCP might be significantly associated with functional outcomes suggesting that it might be a valuable tool for treatment decision-making. This should be confirmed by larger studies.

Identifiants

pubmed: 31346759
doi: 10.1007/s00345-019-02884-7
pii: 10.1007/s00345-019-02884-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1303-1309

Auteurs

Imad Bentellis (I)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France. imad.bentellis@gmail.com.

Mehdi El-Akri (M)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Juliette Hascoet (J)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Quentin Alimi (Q)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Romain Mathieu (R)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Sébastien Vincendeau (S)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Jacques Kerdraon (J)

Department of Physical Medicine and Rehabilitation, University of Rennes, Rennes, France.

Caroline Voiry (C)

Department of Physical Medicine and Rehabilitation, University of Rennes, Rennes, France.

Andrea Manunta (A)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Benoit Peyronnet (B)

Service d'urologie, Department of Urology, CHU Rennes, University of Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH